logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Blaney, Wilson Cecil
    Born in July 1972
    Individual (13 offsprings)
    Officer
    icon of calendar 2022-11-17 ~ now
    OF - Director → CIF 0
  • 2
    Atherton, Paul Richard
    Born in May 1965
    Individual (18 offsprings)
    Officer
    icon of calendar 2021-02-01 ~ now
    OF - Director → CIF 0
  • 3
    TTS PHARMA LIMITED
    icon of addressLiverpool Science Park, 131 Mount Pleasant, Liverpool, England
    Active Corporate (2 parents, 5 offsprings)
    Equity (Company account)
    594,911 GBP2024-12-31
    Person with significant control
    icon of calendar 2016-04-06 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
Ceased 4
  • 1
    Tucker, Mark Rupert
    Director born in April 1965
    Individual (5 offsprings)
    Officer
    icon of calendar 2006-08-10 ~ 2022-11-11
    OF - Director → CIF 0
    Tucker, Mark Rupert
    Individual (5 offsprings)
    Officer
    icon of calendar 2006-08-10 ~ 2022-11-11
    OF - Secretary → CIF 0
  • 2
    Sneddon, Samuel Redcliffe
    Director born in January 1944
    Individual (1 offspring)
    Officer
    icon of calendar 2006-08-10 ~ 2021-01-31
    OF - Director → CIF 0
  • 3
    Tempest, Gareth Nigel
    Director born in July 1960
    Individual (1 offspring)
    Officer
    icon of calendar 2006-08-10 ~ 2009-08-04
    OF - Director → CIF 0
    Tempest, Gareth Nigel
    Company Director born in July 1960
    Individual (1 offspring)
    icon of calendar 2011-02-01 ~ 2016-12-08
    OF - Director → CIF 0
  • 4
    OVALSHELFCO (NUMBER SIXTEEN) LIMITED - 1978-12-31
    icon of address2, Temple Back East, Temple Quay, Bristol
    Active Corporate (11 parents, 37 offsprings)
    Officer
    2011-06-09 ~ 2016-02-29
    PE - Secretary → CIF 0
parent relation
Company in focus

ENDOPURE MEDICAL LIMITED

Previous name
TRANSDERMAL TECHNOLOGY & SYSTEMS (TTS) LIMITED - 2022-11-25
Standard Industrial Classification
21100 - Manufacture Of Basic Pharmaceutical Products
82990 - Other Business Support Service Activities N.e.c.
Brief company account
Property, Plant & Equipment
2,342 GBP2024-12-31
3,122 GBP2023-12-31
Fixed Assets
2,342 GBP2024-12-31
3,122 GBP2023-12-31
Debtors
55,715 GBP2024-12-31
1,805 GBP2023-12-31
Cash at bank and in hand
4,278 GBP2024-12-31
3,330 GBP2023-12-31
Current Assets
59,993 GBP2024-12-31
5,135 GBP2023-12-31
Creditors
Current
15,023 GBP2024-12-31
500 GBP2023-12-31
Net Current Assets/Liabilities
44,970 GBP2024-12-31
4,635 GBP2023-12-31
Total Assets Less Current Liabilities
47,312 GBP2024-12-31
7,757 GBP2023-12-31
Creditors
Non-current
1,306,411 GBP2024-12-31
1,243,417 GBP2023-12-31
Net Assets/Liabilities
-1,259,099 GBP2024-12-31
-1,235,660 GBP2023-12-31
Equity
Called up share capital
13 GBP2024-12-31
13 GBP2023-12-31
Share premium
741,325 GBP2024-12-31
741,325 GBP2023-12-31
Retained earnings (accumulated losses)
-2,000,437 GBP2024-12-31
-1,976,998 GBP2023-12-31
Equity
-1,259,099 GBP2024-12-31
-1,235,660 GBP2023-12-31
Average Number of Employees
22024-01-01 ~ 2024-12-31
22023-01-01 ~ 2023-12-31
Intangible Assets - Gross Cost
Other than goodwill
138,455 GBP2023-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Other than goodwill
138,455 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
129,047 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
126,705 GBP2024-12-31
125,925 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
780 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment
Plant and equipment
2,342 GBP2024-12-31
3,122 GBP2023-12-31
Trade Debtors/Trade Receivables
Current, Amounts falling due within one year
11,658 GBP2024-12-31
Other Debtors
Current, Amounts falling due within one year
42,979 GBP2024-12-31
1,727 GBP2023-12-31
Debtors
Current, Amounts falling due within one year
54,637 GBP2024-12-31
1,727 GBP2023-12-31
Trade Creditors/Trade Payables
Current
14,523 GBP2024-12-31
Other Creditors
Current
500 GBP2024-12-31
500 GBP2023-12-31
Amounts owed to group undertakings
Non-current
1,306,411 GBP2024-12-31
1,243,417 GBP2023-12-31

  • ENDOPURE MEDICAL LIMITED
    Info
    TRANSDERMAL TECHNOLOGY & SYSTEMS (TTS) LIMITED - 2022-11-25
    Registered number 05902779
    icon of addressLiverpool Science Park, 131 Mount Pleasant, Liverpool L3 5TF
    PRIVATE LIMITED COMPANY incorporated on 2006-08-10 (19 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2024-08-05
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.